Bitte benutzen Sie diese Referenz, um auf diese Ressource zu verweisen:
doi:10.22028/D291-39206
Titel: | Local Application of Mineral-Coated Microparticles Loaded With VEGF and BMP-2 Induces the Healing of Murine Atrophic Non-Unions |
VerfasserIn: | Orth, M. Fritz, T. Stutz, J. Scheuer, C. Ganse, B. Bullinger, Y. Lee, J. S. Murphy, W. L. Laschke, M. W. Menger, M. D. Pohlemann, T. |
Sprache: | Englisch |
Titel: | Frontiers in Bioengineering and Biotechnology |
Bandnummer: | 9 |
Verlag/Plattform: | Frontiers |
Erscheinungsjahr: | 2022 |
Freie Schlagwörter: | non-union mineral-coated microparticles VEGF BMP-2 bone healing fracture |
DDC-Sachgruppe: | 610 Medizin, Gesundheit |
Dokumenttyp: | Journalartikel / Zeitschriftenartikel |
Abstract: | Deficient angiogenesis and disturbed osteogenesis are key factors for the development of nonunions. Mineral-coated microparticles (MCM) represent a sophisticated carrier system for the delivery of vascular endothelial growth factor (VEGF) and bone morphogenetic protein (BMP)-2. In this study, we investigated whether a combination of VEGF- and BMP2-loaded MCM (MCM + VB) with a ratio of 1:2 improves bone repair in non-unions. For this purpose, we applied MCM + VB or unloaded MCM in a murine non-union model and studied the process of bone healing by means of radiological, biomechanical, histomorphometric, immunohistochemical and Western blot techniques after 14 and 70 days. MCM-free non-unions served as controls. Bone defects treated with MCM + VB exhibited osseous bridging, an improved biomechanical stiffness, an increased bone volume within the callus including ongoing mineralization, increased vascularization, and a histologically larger total periosteal callus area consisting predominantly of osseous tissue when compared to defects of the other groups. Western blot analyses on day 14 revealed a higher expression of osteoprotegerin (OPG) and vice versa reduced expression of receptor activator of NF-κB ligand (RANKL) in bone defects treated with MCM + VB. On day 70, these defects exhibited an increased expression of erythropoietin (EPO), EPOreceptor and BMP-4. These findings indicate that the use of MCM for spatiotemporal controlled delivery of VEGF and BMP-2 shows great potential to improve bone healing in atrophic non-unions by promoting angiogenesis and osteogenesis as well as reducing early osteoclast activity. |
DOI der Erstveröffentlichung: | 10.3389/fbioe.2021.809397 |
URL der Erstveröffentlichung: | https://www.frontiersin.org/articles/10.3389/fbioe.2021.809397 |
Link zu diesem Datensatz: | urn:nbn:de:bsz:291--ds-392064 hdl:20.500.11880/35335 http://dx.doi.org/10.22028/D291-39206 |
ISSN: | 2296-4185 |
Datum des Eintrags: | 3-Mär-2023 |
Fakultät: | M - Medizinische Fakultät |
Fachrichtung: | M - Chirurgie M - Neurochirurgie |
Professur: | M - Prof. Dr. med. Bergita Ganse M - Prof. Dr. Michael D. Menger M - Prof. Dr. Joachim Oertel M - Prof. Dr. Tim Pohlemann |
Sammlung: | SciDok - Der Wissenschaftsserver der Universität des Saarlandes |
Dateien zu diesem Datensatz:
Datei | Beschreibung | Größe | Format | |
---|---|---|---|---|
fbioe-09-809397.pdf | 4,06 MB | Adobe PDF | Öffnen/Anzeigen |
Diese Ressource wurde unter folgender Copyright-Bestimmung veröffentlicht: Lizenz von Creative Commons